External Contributor

These are all the posts from our lovely external contributors. If you want to contribute too, drop us a line at contact-at-labiotech.eu

ipsen paris pharma

31/03/2020 3 mins

Ipsen Resumes Phase III Testing for Rare Disease Drug and Abandons Pediatric Trial

PCR novacyt coronavirus test

26/03/2020 3 mins

Novacyt Launches Two-Hour Coronavirus Test After FDA Approval

Peanut Allergy Toddlers DBV Technologies

25/03/2020 2 mins

DBV Technologies’ Peanut Allergy Treatment Hits FDA Setback

life sciences partners fundraise

10/03/2020 2 mins

LSP Raises €528M in Largest European Life Sciences Investment Fund

immunocore cancer immunotherapy

04/03/2020 2 mins

Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B

CN Bio - organ on a chip

04/03/2020 2 mins

CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout

14/02/2020 2 mins

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

izana antibody coronavirus

13/02/2020 2 mins

French Partnership Deploys AI for Antibody Drug Discovery

bayer crop breeding meiogenix

10/02/2020 2 mins

Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding

Lunaphore - cancer research tools article

06/02/2020 2 mins

Lunaphore Raises €21.5M to Develop Automated Cancer Research Tools

dna synthesis synthetic biology camena bioscience

06/02/2020 2 mins

Camena Bioscience Hits DNA Synthesis Milestone

maat pharma microbiome therapy cancer

05/02/2020 2 mins

MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost

We use cookies to give you the best experience. If you click on accept, we also use tracking cookies for analytics and advertising purposes. Check our privacy policy for more details. By accepting, you support our independent media and its’ freely accessible content. You may withdraw your consent at any time.